For some patients IBS alternates between constipation IBS-C and diarrhoea IBS-D a subtype known as IBS-M mixed This dual ...
A groundbreaking study suggests that genetic variations in carbohydrate digestion enzymes could hold the key to personalized ...
Bowel movements, bloating, and other digestive issues may not be the easiest topics to discuss with your doctor, but having a ...
Treatment for irritable bowel syndrome (IBS) may start with lifestyle changes like avoiding certain foods and relieving stress. If these don’t work, some medications may help relieve symptoms.
Dietary interventions are a logical place to focus when developing IBS treatment strategies because more than three-quarters of patients with the condition relate their GI symptoms to eating a ...
The research reveals that IBS patients with genetic defects in ­carbohydrate digestion have a better response to particular dietary ­interventions. This could lead to tailored treatments for IBS ...
VANCOUVER, BRITISH COLUMBIA, CANADA, January 24, 2025 /EINPresswire / -- Emergen Research's latest market research report, titled Global Irritable Bowel Syndrome Treatment Market , provides ...
If you’re experiencing IBS pain, it’s always better to get medical attention than to try and tough it out or treat your pain at home. Healthcare professionals can often provide treatment to ...
NeurAxis offers FDA-cleared IB-Stim device for pediatric IBS pain. Despite positive advancements, market recognition lags.
That said, it is important to recognize the role that stress, trauma, and other psychological factors may play in the development of IBS and the severity of symptoms. A treatment plan for IBS ...
Skype hypnotherapy is an effective treatment for people with severe irritable bowel syndrome, a new study has found. The study of 20 patients who had the treatment via the online communications tool ...
Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...